At what ages should low‑dose computed tomography (LDCT) screening be initiated and discontinued for smokers with a ≥20 pack‑year history?

Lung Cancer Screening Age Recommendations for Smokers

For smokers with ≥20 pack-year history, initiate annual low-dose CT (LDCT) screening at age 50 and continue through age 80 years, with no time-since-quitting restriction. 1

Primary Screening Criteria

The most recent and authoritative guideline is the NCCN 2025, which provides the clearest framework 1:

High-Risk Population (Category 1 Evidence)

• Age: ≥50 years
• Smoking exposure: ≥20 pack-years
• No quit-time restriction (critical update from earlier guidelines)

This represents an evolution from older criteria. The NCCN explicitly removed the 15-year quit restriction in 2022 because lung cancer risk remains more than 3-fold higher in former smokers even after 25 years since quitting, and 40.8% of lung cancers occur in individuals who quit >15 years ago 1.

Comparison with Other Guidelines

While multiple organizations have issued recommendations, there are important differences:

USPSTF 2021 (Grade B Recommendation)

• Age 50-80 years
• ≥20 pack-years
• Currently smoking OR quit within past 15 years 2

Critical limitation: The 15-year quit restriction creates a paradoxical incentive structure where former smokers may be encouraged to resume smoking or misrepresent their history to remain eligible 1.

Older NCCN 2014 Criteria (Now Superseded)

• Age 55-74 years with ≥30 pack-years (Category 1)
• Age ≥50 years with ≥20 pack-years plus additional risk factors (Category 2B) 3

CHEST 2021 Guidelines

• Strong recommendation: Age 55-77 years, ≥30 pack-years, quit ≤15 years
• Weak recommendation: Age 50-80 years, ≥20 pack-years, quit ≤15 years 4

Recommended Approach

Use the NCCN 2025 criteria as your primary framework 1:

1. Initiation age: 50 years
2. Discontinuation age: 80 years
3. Smoking threshold: ≥20 pack-years
4. Quit duration: No restriction (major advantage over USPSTF)

When to Consider Earlier Screening (Age ≥50 with <20 pack-years)

Screen if patient has ≥20 years of smoking history (regardless of pack-years) PLUS one additional risk factor 1:

• Personal cancer history (lung, lymphoma, head/neck, other smoking-related cancers)
• Prior chest radiation or alkylating agent treatment
• Lung disease history (COPD, pulmonary fibrosis)
• Family history of lung cancer in first-degree relatives
• Occupational exposures (asbestos, radon)

Key Implementation Points

Shared Decision-Making Required

Before first screening, discuss 1, 4:

• Benefits: 20-21% reduction in lung cancer mortality 2, 5
• Harms: False positives (1.9-2.5 per person screened), overdiagnosis (83-94 per 100,000), radiation exposure 6
• Not all lung cancers will be detected

Screening Frequency

• Annual LDCT is standard 1, 2
• Biennial screening for ages 50-60 may be considered in resource-limited settings (preserves 95.9% of benefits with 20.6% fewer scans) 7

Discontinuation Criteria

Stop screening when 1, 4:

• Age >80 years
• Life expectancy substantially limited by comorbidities
• Patient unable or unwilling to undergo curative lung surgery
• Patient develops health problem precluding definitive treatment

Common Pitfalls to Avoid

1. Don't exclude former smokers who quit >15 years ago - This is the single largest group inappropriately excluded from screening under older USPSTF criteria 1

2. Don't use chest X-ray for screening - Multiple guidelines explicitly recommend against this 3

3. Don't screen outside of qualified programs - Screening should occur in facilities with multidisciplinary teams experienced in LDCT interpretation and nodule management 8, 4

4. Don't forget smoking cessation counseling - Screening is not a substitute for cessation efforts 3

Addressing Health Disparities

The NCCN 2025 criteria (age ≥50, ≥20 pack-years, no quit restriction) improve equity compared to USPSTF 2021 criteria 1:

• Increases eligible population from 15 million to 19.2 million
• Better captures women and Black individuals who have different smoking patterns 6, 9
• Eliminates unnecessary complexity that creates barriers to referral

Bottom line: Start at age 50 with ≥20 pack-years, continue annually through age 80, and eliminate the quit-time restriction to maximize mortality benefit while improving equity.